1. Home
  2. GEO vs TSHA Comparison

GEO vs TSHA Comparison

Compare GEO & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Geo Group Inc (The) REIT

GEO

Geo Group Inc (The) REIT

HOLD

Current Price

$14.55

Market Cap

2.0B

ML Signal

HOLD

Logo Taysha Gene Therapies Inc.

TSHA

Taysha Gene Therapies Inc.

HOLD

Current Price

$4.46

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GEO
TSHA
Founded
1984
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.2B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
GEO
TSHA
Price
$14.55
$4.46
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
9
Target Price
$39.67
$10.56
AVG Volume (30 Days)
3.0M
2.2M
Earning Date
05-13-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
727.27
62.50
EPS
1.82
N/A
Revenue
$2,263,420,000.00
$8,333,000.00
Revenue This Year
$13.74
N/A
Revenue Next Year
$9.99
N/A
P/E Ratio
$7.75
N/A
Revenue Growth
3.85
N/A
52 Week Low
$12.51
$1.13
52 Week High
$32.09
$6.02

Technical Indicators

Market Signals
Indicator
GEO
TSHA
Relative Strength Index (RSI) 47.30 43.04
Support Level $14.27 $4.39
Resistance Level $15.54 $5.16
Average True Range (ATR) 0.72 0.21
MACD 0.04 -0.00
Stochastic Oscillator 59.03 18.83

Price Performance

Historical Comparison
GEO
TSHA

About GEO Geo Group Inc (The) REIT

The GEO Group Inc specializes in detention facilities and community reentry centers. It operates in four segments: U.S. Secure Services, which mainly encompasses U.S.-based secure services business; Electronic Monitoring and Supervision Services, which conducts its services in the United States, represents services provided to adults for monitoring services and evidence-based supervision and treatment programs for community-based parolees, probationers, and pretrial defendants; Reentry Services conducts its services in the United States represents services provided to adults for residential and non-residential treatment, educational and community-based programs, pre-release and half-way house programs; and International Services.

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.

Share on Social Networks: